Blockbuster
16:00 :
Blockbuster wins debt reprieve, warns of liquidation -
Blockbuster Inc has won its second debt-payment deadline extension in as many months, but the struggling video rental chain reported a wider loss and warned it might have to liquidate, sending its shares plummeting more than 20 percent ...
11:28 :
Blockbuster posts loss, extends debt pact -
Blockbuster Inc posted a wider quarterly loss but said it had extended a debt-payment deadline to the end of September to give it time for recapitalization talks with debtors and strategic parties.
16:19 :
Barnes & Noble predicament -
Aug 4 - Reuters Breakingviews Columnist Robert Cyran says Barnes & Noble's cash flow is sinking and technological shifts look primed to worsen, mirroring the downfall of video rental giant Blockbuster.
20:54 :
U.S. experts back AstraZeneca blood thinner -
ADELPHI, Maryland (Reuters) - U.S. advisers backed a potential
blockbuster blood thinner from AstraZeneca on Wednesday, a victory for a company seeking new drugs to offset expiring patents on some of its best-selling medicines.
07:38 :
LG misses Q2 estimates, lacks blockbuster phones -
SEOUL (Reuters) - LG Electronics Inc the world's No.2 TV maker, faces more pressure to turn around its mobile business and tackle its underperforming shares after it missed forecasts with a 90 percent slump in quarterly profit.
15:23 :
Evanovich Takes Her Bounty to Random House -
The
blockbuster novelist Janet Evanovich has taken her scrappy bounty-hunter heroine Stephanie Plum to Random House, leaving her longtime publisher, St. Martin's Press, after more than two months of contract negotiations fell through.
19:31 :
Blockbuster CEO: No emergency meeting -
Blockbuster CEO Jim Keyes has sent a letter to dissident shareholders saying an emergency meeting to deal with the company’s July 1 delisting from the New York Stock Exchange is not necessary.
06:33 :
GSK to take £1.6bn legal charge -
Drugs group moves to resolve resolve several long-running legal battles, including a probe into a former manufacturing plant in Puerto Rico and litigation related to Paxil and Avandia, two of its
blockbuster drugs